The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis

Pharmazie

Volumn 59, Issue 7, 2004, Pages 573-574

  Melkusova S ^a   Bujdáková, Helena ^a   Vollekova A ^b   Myoken, Y ^c   Mikami, Y ^d  

^a Physics and Informatics   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c Hiroshima Red Cross/Atom Bomb S H ^*  (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINO 2 N PENTYLTHIOBENZOTHIAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BENZOTHIAZOLE DERIVATIVE; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CONCENTRATION RESPONSE; DRUG EFFICACY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; LIPOPROTEINS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; THIAZOLES;

EID: 3242707862     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bachman SP, Patterson TF, López-Ribot JL (2002) In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol 40: 2228-2230.
2. Bujdáková H, Múčková M (1994) Antifungal activity of a new benzothiazole derivative against Candida in vitro and in vivo. Int J Antimicrob Agents 4: 303-308.
3. Bujdáková H, Múčková M, Klobušický M, Sidóvá E (1995) Efficacy of 6-amino-2-n-pentylthiobenzothiazole on Trichophyton in vitro and in vivo. Mycopathology 130: 141-145.
4. Fromtling RA (2002) Micafungin sodium (FK-463). Drugs Today 38: 245-257.
5. Kartsonis N, DiNubile MJ, Bartizal K, Hicks PS, Ryan D, Sable CA (2002) Efficacy of caspofungin in the treatment of esophageal candidiasis resistant to fluconazole. J AIDS 31: 183-187.
6. Kuchta T, Léka C, Farkaš P, Bujdáková H, Belajová E, Russel N (1995) Inhibition of sterol 4-demethylation in Candida albicans by 6-amino-2n-pentylthiobenzothiazole, a novel mechanism of action for an antifungal agent. Antimicrob Agents Chemother 39: 1538-1541.
7. Martinez M, López-Ribot JL, Kirkpatrick WR, Coco BJ, Bachmann SP, Patterson TF (2002) Replacement of Candida albicans with Candida dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 40: 3135-3139.
8. Mikamo H, Sato Y, Tamaya T (2000) In vitro antifungal activity of FK 463, a new water-soluble echinocandin-like lipopeptide. J Antimicrob Chemother 46: 485-487.
9. Múčková M, Bujdáková H, Kuchta T (2000) Synergy between 6-amino-2-n-pentylthiobenzothiazole and ergosterol biosynthesis - inhibiting antimycotics against Candida albicans. Int J Antimicrob Chemother 15: 153-154.
10. Perea S, López-Ribot JL, Wickes BL, Kirkpatrick WR, Dib OP, Bachmann SP, Keller SM, Martinez M, Patterson TF (2002) Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 46: 1695-1703.
11. Watanabe K, Katsu M, Mekha N, Poonwan N, Ando A, Mikami Y (2001) Preparation of a new specific PCR primer for the identification of Candida dubliniensis isolates from clinical and environmental sources. Report of Environmental Research Organization of Chiba University 27: 15-19.